Latest News

Ocrelizumab approved by Medsafe

December 22, 2017 | Advocacy, Treatments

Media Release – 22 December 2017 The Multiple Sclerosis Society of New Zealand (MSNZ) is pleased that Medsafe[1] has approved the registration of ocrelizumab (Ocrevus®) for both Relapsing (RMS) and Primary Progressive (PPMS) multiple sclerosis (MS) in New Zealand.   […]


Oceans of Hope returns to NZ shores searching for crew

December 18, 2017 | Uncategorised

  In May 2015 over 85 people with MS (PwMS) travelled to Auckland to welcome Oceans of Hope, a 67-foot sailing vessel, which left Denmark in 2014 for a 17-month long journey circumnavigating the globe and providing taster sessions for […]


Educational lectures on the future of MS available now

December 7, 2017 | Research, Treatments, Uncategorised

As part of Multiple Sclerosis NZ’s 50th Anniversary, in October we held a lecture evening on the future of MS treatments. To watch lectures from two prominent speakers in their field, click on the lecture titles below: Stem Cell Transplantation […]